Skip to main content
Skip to main content
XRN logo

Chiron Real Estate Inc. (XRN) Stock Analysis

$37.03 +$0.32 (+0.87%) |Fair · 56
Chiron Real Estate Inc. (XRN) bottom line: Split View — our Council read (52/100) and AI Score (56/100) broadly agree. Strongest signal: Izzy Englander bullish · Biggest watch-out: Growth Durability weak.
MCap: $490M| Vol: 104.4K| Target: $39.00 (+5.3%)| 52-wk range: $29.05 – $39.93
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Chiron Real Estate Inc. (XRN) trades at $37.03 with AI Score 56/100 (Grade B). Chiron Real Estate Inc. Market cap: $490M, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026
Chiron Real Estate Inc. (XRN) is a REIT focused on acquiring and leasing purpose-built healthcare facilities to healthcare systems and physician groups. Founded in 2011, the company operates in the financial services sector, specifically within the industrial REIT segment.

XRN stock analysis for 2026: Analysts have set a consensus price target of $39.00 for Chiron Real Estate Inc., suggesting 5.3% upside from the current price of $37.03. The AI MoonshotScore is 56/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the XRN film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 52/100 · B

XRN: the 3 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.

How is this calculated? →
MoonshotScore · Growth Potential · 56/100
Business Quality
Neutral Is this a genuinely good business?
Financial Safety
Strong Could this blow up on me?
Valuation
Neutral Am I paying a fair price?
Growth Durability
Negative Is the growth real and likely to last?
Momentum
Neutral Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Neutral
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Chiron Real Estate Inc. (XRN) Financial Services Profile

CEOMark O. Decker
Employees26
HeadquartersBethesda, US
IPO Year2016

Chiron Real Estate Inc. (XRN) is a REIT specializing in healthcare facilities, acquiring and leasing properties to healthcare systems and physician groups. With a focus on purpose-built assets, XRN offers a high dividend yield, but operates with a negative profit margin in a competitive REIT landscape.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: Mar 16, 2026

What Is the Investment Thesis for XRN?

As of Mar 16, 2026 — figures reflect the data available on that date.

Chiron Real Estate Inc. (XRN) presents a mixed investment case. The company's high dividend yield of 9.58% may attract income-seeking investors. However, the negative profit margin of -3.7% and a high P/E ratio of -78.91 raise concerns about long-term profitability. The company's focus on purpose-built healthcare facilities offers a degree of specialization within the REIT sector, potentially providing a competitive edge. Growth catalysts include expanding its portfolio of healthcare properties and capitalizing on the increasing demand for medical services. Potential risks include rising interest rates, which could increase borrowing costs and impact property valuations, and the competitive nature of the REIT industry. Investors should carefully weigh the potential benefits of the high dividend yield against the financial challenges and market risks before investing in XRN.

Based on FMP financials and quantitative analysis

XRN Key Highlights

Market capitalization of $490M indicates a mid-sized REIT.

  • Negative P/E ratio of -78.91 suggests current earnings are not supporting the stock price.
  • Dividend yield of 9.58% offers a high income stream to investors.
  • Negative profit margin of -3.7% reflects operational challenges in generating profits.
  • Beta of 1.21 indicates higher volatility compared to the overall market.

Who Are XRN's Competitors?

XRN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
WELL Welltower Inc. $237.42 +0.72% $171B 57
MPW Medical Properties Trust, Inc. $5.36 +1.52% $3.22B 50
ILPT Industrial Logistics Properties Trust $8.34 -0.60% $557M 30
EFRTF Nexus Industrial REIT $5.86 +3.37% $421M 43
TPTA Terra Property Trust, Inc. 6.00 $24.73 -0.08% $602M 41
AOMN Angel Oak Mortgage REIT, Inc. $25.16 -0.02% $627M 84
LAND Gladstone Land Corporation $8.69 +0.93% $375M 31
NHPAP National Healthcare Properties, Inc. $25.20 +0.00% $714M 33

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are XRN's Key Strengths?

Specialization in healthcare facilities.

  • High dividend yield.
  • Established relationships with healthcare providers.
  • Focus on purpose-built properties.

What Are XRN's Weaknesses?

Negative profit margin.

  • High P/E ratio.
  • Smaller market capitalization compared to competitors.
  • Dependence on healthcare sector performance.

What Could Drive XRN Stock Higher?

Potential acquisitions of new healthcare facilities to expand the portfolio.

  • Increasing demand for healthcare services driving rental income growth.
  • Strategic partnerships with healthcare systems securing long-term leases.
  • Implementation of cost-saving measures to improve profit margins.

What Are the Key Risks for XRN?

Financial-distress signal — its Altman Z-Score of 0.48 sits in the distress zone (elevated bankruptcy risk).

  • Rising interest rates increasing borrowing costs.
  • Economic downturn impacting healthcare spending.
  • Competition from other REITs for acquisitions and tenants.
  • Changes in healthcare regulations affecting property values.
  • Negative profit margin impacting financial performance.

What Are the Growth Opportunities for XRN?

  • Expansion of Healthcare Facility Portfolio: Chiron Real Estate can grow by acquiring additional purpose-built healthcare facilities in strategic locations. The market for healthcare real estate is expanding, driven by the aging population and increasing demand for medical services. By focusing on high-growth markets and partnering with leading healthcare systems, Chiron Real Estate can increase its portfolio size and generate higher rental income. This expansion could add significantly to revenue within the next 3-5 years, with a potential market size of several billion dollars.
  • Strategic Partnerships with Healthcare Providers: Collaborating with healthcare systems and physician groups can provide Chiron Real Estate with a steady stream of tenants and long-term lease agreements. By offering customized real estate solutions and building strong relationships with key healthcare providers, Chiron Real Estate can secure its position as a preferred landlord. These partnerships can lead to increased occupancy rates and stable cash flows, enhancing the company's financial performance. The timeline for establishing such partnerships is ongoing, with continuous efforts to engage with healthcare providers.
  • Focus on Specialized Healthcare Facilities: Specializing in specific types of healthcare facilities, such as rehabilitation centers or medical office buildings, can differentiate Chiron Real Estate from its competitors. By developing expertise in these niche areas, the company can attract tenants seeking specialized spaces and services. This specialization can also lead to higher rental rates and increased property values. The market for specialized healthcare facilities is growing, driven by the increasing complexity of medical treatments and the need for specialized care environments. This strategy can yield results within 2-4 years.
  • Geographic Diversification: Expanding into new geographic markets can reduce Chiron Real Estate's reliance on specific regions and diversify its revenue streams. By targeting areas with strong demographics and growing healthcare demands, the company can capitalize on new opportunities and mitigate risks associated with regional economic downturns. Geographic diversification can also provide access to new tenants and investment opportunities. The timeline for geographic expansion is ongoing, with continuous assessment of potential markets and investment opportunities.
  • Enhancing Property Management Efficiency: Improving property management practices can reduce operating costs and increase net operating income. By implementing advanced technologies and streamlining processes, Chiron Real Estate can enhance the efficiency of its property management operations. This includes optimizing energy consumption, reducing maintenance expenses, and improving tenant satisfaction. The benefits of enhanced property management efficiency can be realized within 1-2 years, leading to improved financial performance and increased shareholder value.

What Are XRN's Competitive Advantages?

  • Focus on purpose-built healthcare facilities provides a niche market.
  • Long-term lease agreements with healthcare providers ensure stable income.
  • Expertise in healthcare real estate requirements.
  • Established relationships with healthcare systems and physician groups.

What Does XRN Do?

Global Medical REIT, Inc., now known as Chiron Real Estate Inc. (XRN), was established on March 18, 2011, and is headquartered in Bethesda, MD. The company's core business revolves around acquiring and managing a portfolio of purpose-built healthcare facilities. These properties are then leased to healthcare systems and physician groups, providing essential infrastructure for medical service delivery. Chiron Real Estate's strategy focuses on identifying and securing facilities specifically designed to meet the unique needs of healthcare providers, ensuring functionality and efficiency. The company's portfolio includes medical office buildings, rehabilitation facilities, and other specialized healthcare properties. By concentrating on this niche within the REIT sector, Chiron Real Estate aims to provide stable income and long-term growth for its investors. The company's operations are primarily within the United States, targeting markets with growing healthcare demands and favorable demographics. Chiron Real Estate's approach involves careful property selection, active asset management, and strategic leasing to maintain high occupancy rates and maximize returns. The company's growth is driven by the increasing demand for healthcare services, an aging population, and the ongoing shift towards outpatient care. Chiron Real Estate seeks to capitalize on these trends by expanding its portfolio and strengthening its relationships with leading healthcare providers.

What Products and Services Does XRN Offer?

  • Acquires purpose-built healthcare facilities.
  • Leases properties to healthcare systems and physician groups.
  • Manages a portfolio of medical office buildings.
  • Provides real estate solutions for healthcare providers.
  • Focuses on properties designed for medical use.
  • Operates primarily in the United States.
  • Aims to provide stable income and long-term growth.

How Does XRN Make Money?

  • Acquires healthcare facilities using a combination of debt and equity financing.
  • Generates revenue through rental income from leasing properties to healthcare tenants.
  • Manages properties to maintain high occupancy rates and tenant satisfaction.
  • Distributes a portion of its income to shareholders through dividends.

What Industry Does XRN Operate In?

Chiron Real Estate Inc. operates within the REIT (Real Estate Investment Trust) sector, specifically focusing on industrial REITs that own and manage healthcare facilities. The REIT sector is influenced by interest rates, economic growth, and demographic trends. The increasing demand for healthcare services, driven by an aging population and technological advancements, supports the growth of healthcare-related REITs. Competition within the sector is intense, with numerous REITs vying for acquisitions and tenants. Key players include large, diversified REITs and smaller, specialized REITs like Chiron Real Estate. Market trends include a growing emphasis on outpatient facilities and medical office buildings, aligning with Chiron Real Estate's focus.

Who Are XRN's Key Customers?

  • Healthcare systems seeking specialized facilities.
  • Physician groups requiring medical office space.
  • Hospitals needing outpatient facilities.
  • Rehabilitation centers looking for suitable properties.
AI Confidence: 81% Updated: Mar 16, 2026

Company Profile

Chiron Real Estate Inc. operates in the REIT - Healthcare Facilities industry within the Real Estate sector. It is headquartered in Bethesda, US. The company is led by CEO Mark O. Decker Jr.. XRN has traded publicly since 2016.

F-Score 8/9

Financial Health

Chiron Real Estate Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.48 places it in the distress zone, a signal of elevated financial risk.

ROE 11%

Key Financial Metrics

Return on equity for Chiron Real Estate Inc. stands at 10.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. XRN trades at a trailing price-to-earnings ratio of 8.46, below the Financial Services sector average of ~18x. Its free cash flow yield is -38.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 20.79 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 11.8%, the inverse of the P/E and a quick read on earnings relative to price.

XRN Valuation & Market Position

With a $490M market cap, Chiron Real Estate Inc. sits in the small-cap segment of the market. Relative to its peer group, XRN's quantitative score of 56/100 is above the peer average of 44/100.

FY2026 est

Forward Outlook

Wall Street analysts project Chiron Real Estate Inc. revenue of about $152.9M for fiscal 2026, with EPS near $-0.86. The estimate reflects 4 contributing analysts.

XRN Financials

Fundamental Snapshot

Revenue Growth (FY)
+16.3%
Net Income Growth (FY)
-188.0%
EPS Growth (FY)
-393.5%
Free Cash Flow Growth (FY)
+67.8%
P/E (TTM)
8.5
Return on Equity (TTM)
+10.8%
Current Ratio
20.8
EV/EBITDA (TTM)
7.0

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Specialization in healthcare facilities.
  • High dividend yield.
  • Established relationships with healthcare providers.
  • Focus on purpose-built properties.

Bear Case

  • Negative profit margin.
  • High P/E ratio.
  • Smaller market capitalization compared to competitors.
  • Dependence on healthcare sector performance.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

XRN Latest News

No recent news available for XRN.

XRN Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for XRN.

Price Targets

Consensus target: $39.00

XRN MoonshotScore

56/100

What does this score mean?

The MoonshotScore rates XRN 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Mark O. Decker

CEO

Mark O. Decker serves as the CEO of Chiron Real Estate Inc. His background includes extensive experience in real estate investment and management. Prior to joining Chiron Real Estate, Decker held leadership positions at various real estate firms, where he oversaw property acquisitions, leasing, and development projects. He has a proven track record of driving growth and improving operational efficiency. Decker's expertise in healthcare real estate and his strategic vision are instrumental in guiding Chiron Real Estate's growth and success.

Track Record: Under Mark O. Decker's leadership, Chiron Real Estate has focused on expanding its portfolio of purpose-built healthcare facilities and strengthening its relationships with healthcare providers. He has overseen strategic acquisitions and leasing initiatives that have contributed to the company's growth. Decker's focus on operational efficiency and tenant satisfaction has helped to maintain high occupancy rates and stable cash flows. His leadership is crucial for navigating the competitive REIT landscape and delivering long-term value to shareholders.

Common Questions About XRN (Financial Services)

What does the AI Score mean for XRN?

XRN holds an AI Score of 56/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Chiron Real Estate Inc. (XRN) is a REIT focused on acquiring and leasing purpose-built healthcare facilities to healthcare systems and physician groups. Founded in 2011, the company operates in …

What does Chiron Real Estate Inc. do?

Chiron Real Estate Inc. (XRN) is a real estate investment trust (REIT) that specializes in acquiring, owning, and leasing purpose-built healthcare facilities. The company focuses on properties such as medical office buildings, rehabilitation centers, and other specialized healthcare facilities. These properties are leased to healthcare systems and physician groups, providing essential infrastructure for medical service delivery.

What are the main risks for XRN?

The main risks for Chiron Real Estate Inc. (XRN) include rising interest rates, which could increase borrowing costs and impact property valuations. An economic downturn could also negatively affect healthcare spending and rental income. Increased competition from other REITs for acquisitions and tenants poses a threat to the company's growth.

What regulatory challenges does Chiron Real Estate Inc. face?

As a REIT, Chiron Real Estate Inc. faces regulatory challenges related to maintaining its REIT status, which requires distributing a significant portion of its taxable income to shareholders. The company must also comply with regulations governing real estate investments and healthcare facilities. Capital requirements include maintaining sufficient capital to fund property acquisitions and renovations.

How does Chiron Real Estate Inc.'s dividend policy affect its growth strategy?

Chiron Real Estate Inc.'s dividend policy, characterized by a high dividend yield of 9.58%, can impact its growth strategy by limiting the amount of capital available for reinvestment in new property acquisitions or development projects. While the high dividend yield attracts income-seeking investors, it also reduces the company's ability to fund growth initiatives internally.

What are the key factors to evaluate for XRN?

Chiron Real Estate Inc. (XRN) holds an AI score of 56/100 (moderate). Analysts target $39.00 (+5%). (XRN) presents a mixed investment case. Not financial advice.

How frequently does XRN data refresh on this page?

XRN's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven XRN's recent stock price performance?

Chiron Real Estate Inc. (XRN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialization in healthcare facilities. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider XRN overvalued or undervalued right now?

Chiron Real Estate Inc. (XRN) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $39.00 (+5%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • AI analysis is pending and may provide further insights.
  • Market conditions and company performance can change over time.
Data Sources

Popular Stocks

More Stocks We Cover